Stay updated on Quizartinib Plus FLAG-IDA in AML Clinical Trial

Sign up to get notified when there's something new on the Quizartinib Plus FLAG-IDA in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Quizartinib Plus FLAG-IDA in AML Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T15:48:45.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A sitewide notice says federal agencies are transitioning to the term “Super Intelligence” in place of “Artificial Intelligence,” and that both terms may appear in NIH content during the transition.
    Difference
    0.7%
    Check dated 2026-10-25T15:43:31.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision label changed from v3.7.1 to v3.7.2; the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-18T22:11:50.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T22:09:05.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry for version v3.7.0 and removes the previous v3.6.6 entry, reflecting an updated history log.
    Difference
    0.1%
    Check dated 2026-09-20T22:28:55.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Adds a new revision entry 'Revision: v3.6.6' to the study record history and removes the previous 'Revision: v3.6.5' entry from the visible list. This brings the history up to date with the latest revision.
    Difference
    0.1%
    Check dated 2026-08-30T21:49:21.000Z thumbnail image

Stay in the know with updates to Quizartinib Plus FLAG-IDA in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Quizartinib Plus FLAG-IDA in AML Clinical Trial page.